Examens Pharmaceutiques Objectifs et Structurés (EPOS), une (R)évolution des évaluations en pharmacie: Retour d’expérience lilloise [0.03%]
结构化和目标导向的药学考试（EPOS）：药学评估的（R）革命：里尔经验教训回顾
Cyrille Berlemont,Yanèle Poteaux,Anne Garat et al.
Cyrille Berlemont et al.
Objectives: The aim of this work is to evaluate the implementation of Objective Structured Practical Examinations (OSPE) at the Lille Faculty of Pharmacy as part of the skills assessment of 6th year pharmacy students. ...
Design, development and evaluation of curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance solubility and improve efficacy in MCF-7 cell line by Quality by Design [0.03%]
基于质量源于设计的姜黄素(姜黄)磷脂纳米载体包封技术研究、开发及评价以提高溶解度和MCF-7细胞系的效力
Vaibhav Bhadange,Supriya Jogdand,Ankita Kawtikwar et al.
Vaibhav Bhadange et al.
Lipid-based excipients are increasingly used to enhance the stability of innovative drug delivery systems. Phospoholipid nanocarriers, a botanical formulation, are used to build lipophilic molecular complexes, improving stability, absorptio...
Oncology Pharmacy Practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO) [0.03%]
肿瘤药学实践：关键见解、挑战和视角——法国肿瘤药学协会立场文件
Florence Ranchon,Florian Slimano,Isabelle Borget et al.
Florence Ranchon et al.
The role of hospital oncology pharmacists (HOP) in the care of cancer patients has evolved considerably. This evidence led the experts of the French Society for Oncology Pharmacy (SFPO) to write a position paper. The first part presents the...
Investigation of Cytotoxic Activity Properties of Etoxazole Towards Human Cancer and Healthy Cell Lines and Molecular Docking Studies [0.03%]
乙氧扎醇对人类癌细胞系和健康细胞系的细胞毒活性及分子对接研究
Nane İkbal Demet
Nane İkbal Demet
The effect of etoxazole on cancer cells was evaluated in vitro using different cell lines. In this context, its cytotoxic activity on breast (MCF-7), liver (HepG2), colon (DLD-1) and lung (A549) cancer cell lines was investigated. The 3-(4,...
[Incompatibility of injectable drugs in neonatal intensive care: from assessment to implementation of a preventive tool] [0.03%]
新生儿重症监护中注射剂不相容性的评估及预防工具的应用
Marie Guedon,Catherine Mennesson,Baptiste Fulbert et al.
Marie Guedon et al.
Introduction: Complex administration patterns in neonatal intensive care lead to the mixing of several active ingredients on the same route. The aim of this study was to assess the frequency of these concomitant administr...
Geet Raut,Sanjay Sharma
Geet Raut
From 2021-2024, the U.S. Food and Drug Administration (FDA) approved novel drugs, advancing treatments in neurology, oncology, infectious diseases and rare disorders. This review analyzes approval trends, highlighting the targeted diseases ...
Polymeric Nanocomposites: Recent advances, Challenges, Techniques, and Biomedical applications [0.03%]
聚合物纳米复合材料：最近的进展、挑战、技术和生物医学应用
Shivangi Sharma,Madhav Mishra,Harshit Sharma et al.
Shivangi Sharma et al.
Incredible advances in material technology have fueled the adoption of a variety of new materials, hybrids, and composites across a wide range of applications. Among these developing prospects, polymer nanocomposites stand out for their pot...
Physicochemical Stability of a Bevacizumab Biosimilar in Vials and Diluted Preparations: Implications for Hospital Practice and Inventory Management [0.03%]
贝伐珠单抗相似药注射液及稀释后药品的理化稳定性：医院实践和库存管理的影响
Victoire Vieillard,Lucile Foulley,Salim Benkhalifa et al.
Victoire Vieillard et al.
Biosimilars like Vegzelma can significantly enhance access to biologic therapies and reduce healthcare costs, provided that comprehensive stability data is available. This study aimed to provide extended stability data, allowing hospitals a...
[Regulatory requirements for software medical devices: comparison between europe, the united states, and algeria] [0.03%]
欧洲、美国和阿尔及利亚关于软件医疗器械的监管要求比较研究
Belkhatir Mane,Mohammedi Amina,Ould Amar Aida
Belkhatir Mane
Software Medical Device (SWMD) are essential digital tools used in the healthcare sector for various medical applications. Like any medical device, MDS are subject to strict and rigorous regulations that vary from country to country, aiming...
Pharmacological interactions between antihypertensive regimens and drugs prescribed in the emergency department [0.03%]
抗高血压药与急诊科处方药物的药理学相互作用
Lilia Edith Luque Esparza,Marco Antonio Osorio García,Delgadillo Guzmán Dealmy et al.
Lilia Edith Luque Esparza et al.
The risk of drug interactions in patients with HTN is aggravated when prescribing treatments for additional acute pathologies. This can favor adverse reactions to medications or make it difficult to control blood pressure during their stay ...